206 related articles for article (PubMed ID: 24190067)
1. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
[TBL] [Abstract][Full Text] [Related]
2. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
[TBL] [Abstract][Full Text] [Related]
3. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
[TBL] [Abstract][Full Text] [Related]
4. Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.
Andrews PC; Frank R; Junk PC; Kedzierski L; Kumar I; MacLellan JG
J Inorg Biochem; 2011 Mar; 105(3):454-61. PubMed ID: 20851471
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
[TBL] [Abstract][Full Text] [Related]
6. Structural and solution studies of phenylbismuth(III) sulfonate complexes and their activity against Helicobacter pylori.
Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; Huynh KK; Kumar I; Maclellan JG
Dalton Trans; 2010 Oct; 39(40):9633-41. PubMed ID: 20830402
[TBL] [Abstract][Full Text] [Related]
7. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kumar I
Chem Commun (Camb); 2013 Apr; 49(28):2870-2. PubMed ID: 23450139
[TBL] [Abstract][Full Text] [Related]
8. Bismuth(III) complexes derived from α-amino acids: the impact of hydrolysis and oxido-cluster formation on their activity against Helicobacter pylori.
Busse M; Border E; Junk PC; Ferrero RL; Andrews PC
Dalton Trans; 2014 Dec; 43(48):17980-90. PubMed ID: 25310996
[TBL] [Abstract][Full Text] [Related]
9. Comparative stability, toxicity and anti-leishmanial activity of triphenyl antimony(v) and bismuth(v) α-hydroxy carboxylato complexes.
Duffin RN; Blair VL; Kedzierski L; Andrews PC
Dalton Trans; 2018 Jan; 47(3):971-980. PubMed ID: 29260831
[TBL] [Abstract][Full Text] [Related]
10. Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori.
Andrews PC; Ferrero RL; Junk PC; Kumar I; Luu Q; Nguyen K; Taylor JW
Dalton Trans; 2010 Mar; 39(11):2861-8. PubMed ID: 20200713
[TBL] [Abstract][Full Text] [Related]
11. Bismuth(III) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6].
Pathak A; Blair VL; Ferrero RL; Mehring M; Andrews PC
Chem Commun (Camb); 2014 Dec; 50(96):15232-4. PubMed ID: 25341969
[TBL] [Abstract][Full Text] [Related]
12. Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.
Loh A; Ong YC; Blair VL; Kedzierski L; Andrews PC
J Biol Inorg Chem; 2015 Oct; 20(7):1193-203. PubMed ID: 26411702
[TBL] [Abstract][Full Text] [Related]
13. Bismuth coordination networks containing deferiprone: synthesis, characterisation, stability and antibacterial activity.
Burrows AD; Jurcic M; Mahon MF; Pierrat S; Roffe GW; Windle HJ; Spencer J
Dalton Trans; 2015 Aug; 44(31):13814-7. PubMed ID: 26172618
[TBL] [Abstract][Full Text] [Related]
14. Novel class of Bi(iii) hydroxamato complexes: synthesis, urease inhibitory activity and activity against H. pylori.
Keogan DM; Twamley B; Fitzgerald-Hughes D; Griffith DM
Dalton Trans; 2016 Jul; 45(27):11008-14. PubMed ID: 27314129
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
[TBL] [Abstract][Full Text] [Related]
16. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
17. Homo- and heteroleptic bismuth(III/V) thiolates from N-heterocyclic thiones: synthesis, structure and anti-microbial activity.
Luqman A; Blair VL; Brammananth R; Crellin PK; Coppel RL; Andrews PC
Chemistry; 2014 Oct; 20(44):14362-77. PubMed ID: 25224757
[TBL] [Abstract][Full Text] [Related]
18. Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major.
Ong YC; Blair VL; Kedzierski L; Tuck KL; Andrews PC
Dalton Trans; 2015 Nov; 44(41):18215-26. PubMed ID: 26425978
[TBL] [Abstract][Full Text] [Related]
19. Coordination of thiosemicarbazones and bis(thiosemicarbazones) to bismuth(III) as a strategy for the design of metal-based antibacterial agents.
Lessa JA; Reis DC; Da Silva JG; Paradizzi LT; da Silva NF; Carvalho Mde F; Siqueira SA; Beraldo H
Chem Biodivers; 2012 Sep; 9(9):1955-66. PubMed ID: 22976983
[TBL] [Abstract][Full Text] [Related]
20. Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori.
Andrews PC; Deacon GB; Ferrero RL; Junk PC; Karrar A; Kumar I; MacLellan JG
Dalton Trans; 2009 Aug; (32):6377-84. PubMed ID: 19655072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
